Running Title: NOX4-derived ROS drives prostatic stromal transdifferentiation
Introduction
Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are two of the most common diseases affecting elderly males (1) . BPH is a classic age-associated progressive disease present in 20% of men at age 40 with progression to 70% at age 60 (2, 3) . BPH is frequently associated with bothersome lower urinary tract symptoms (LUTS) with a lifetime risk for surgery of 25-30% (4, 5) . PCa is the most common malignant tumor and second leading cause of male cancer death in Western societies. Whereas PCa is rare in men before their fifth decade, approximately 86% of PCa patients are over 65 years (6) . Given their high prevalence, significant morbidity and age-associated incidence, current demographic trends underscore the socioeconomic and medical urgency for a better understanding of BPH and PCa etiology for disease prevention and improved therapeutic intervention.
Whilst distinct pathologies, BPH and PCa are both associated with changes in the stromal microenvironment that actively promote disease development (7, 8) . The BPH and tumoradjacent stroma (the latter also termed reactive stroma) are characterized by increased ECM deposition, capillary density and myofibroblasts, which arise from fibroblast transdifferentiation. In particular, elevated secretion of paracrine-and autocrine-acting mitogenic cytokines and growth factors by myofibroblasts promotes cellular proliferation, angiogenesis and tumorigenesis (9) . Initial treatment for BPH and local-confined PCa exploits the androgen-dependence of the prostate by targeting local/systemic androgen metabolism and/or the androgen receptor itself resulting in apoptosis of androgen-dependent cells and thereby reduced prostate volume (10, 11) . However, neither approach specifically addresses the stromal component of disease. Understanding the mechanisms underlying stromal remodeling in particular fibroblast-to-myofibroblast transdifferentiation may facilitate the development of preventative therapy or more effective treatment strategies.
TGFbeta1 (TGFβ1) is a multifunctional cytokine secreted in elevated concentrations by luminal epithelial cells in BPH (12) and by tumor cells in prostatic intraepithelial neoplasia (PIN), considered to be precursor tumorigenic lesions (13) . Tissue and circulating TGFβ1 levels positively correlate with risk of BPH and PCa with particular alleles predisposing to disease and more rapid tumor progression (14, 15) . We and others previously demonstrated that TGFβ1 induces expression of ECM components and transdifferentiation of primary prostatic stromal fibroblasts (PrSCs) into myofibroblasts (16, 17) . Moreover, exogenous administration of TGFβ1 is sufficient to induce myofibroblast differentiation and collagen production in vivo (18) . Elevated production of TGFβ1 is thus likely a key inducer of pathogenic stromal reorganization. However, the molecular effectors through which TGFβ1 induces transdifferentiation and hence potential therapeutic targets remain unknown.
Various cellular stimuli (e.g. growth factors, cytokines such as TGFβ1, G protein-coupled receptor agonists and stress) induce regulated production of ROS. In such cellular contexts, ROS serve as second signaling messengers regulating diverse physiological processes, including proliferation, apoptosis, cytoskeletal remodeling, differentiation and migration (19) .
The downstream signaling effects of ROS are mediated via reversible oxidative modification of lipids, DNA and specific cysteine residues of certain proteins resulting in altered activity and function. Direct redox modification of transcription factors (NF-κB, AP1, HIF1, p53), protein kinases (MAPKs, PKB, PKC) and protein tyrosine phosphatases (PTPs) has been reported (20) .
The NADPH oxidase (NOX) family is emerging as one of the most important sources of intracellular ROS. NOX enzymes are multisubunit transmembrane proteins that catalyze the reduction of oxygen using cytosolic NADPH as an electron donor generating superoxide, which may be subsequently dismutated to hydrogen peroxide (H 2 O 2 ). In humans, seven NOX enzymes are currently known, NOX1-5 and DUOX1-2 as well as several activator "phox" subunits (21) . Whilst NOX1 plays a role in host defense, ROS produced by other NOX enzymes act as second messenger molecules in signal transduction (21, 22) . NOX4 has been implicated in the differentiation of cardiac fibroblasts associated with cardiac fibrosis and heart failure and lung mesenchymal cells associated with idiopathic lung pulmonary fibrosis (23, 24) . However, the molecular mechanism(s) by which NOX4-derived ROS directed differentiation were not identified.
with the aim of identifying novel therapeutic targets to prevent stromal remodeling in BPH
and PCa. We demonstrate that NOX4-derived ROS are essential signaling mediators of TGFβ1 that coordinate ERK1/2 and JNK spatiotemporal phosphorylation, which subsequently initiate downstream transcriptional programs of cytoskeletal remodeling and fibroblast-to-myofibroblast transdifferentiation. ROS signaling by NOX4 is positively supported by concomitant down-regulation of ROS scavenging enzymes, including several selenoproteins. Our data indicate the potential clinical value of selenium supplementation and/or NOX4 inhibitors in preventing the transformation of stromal cells in BPH and PCa.
Results

Dysregulation of redox-regulating enzymes during prostatic stromal fibroblast transdifferentiation
To investigate the molecular changes during BPH/PCa-associated fibroblast-to-myofibroblast transdifferentiation the expression profiles of TGFβ1-induced transdifferentiated and nontransdifferentiated PrSCs were analyzed by Affymetrix microarray. 1611 genes were identified with at least 2.5 fold change in their expression levels. Consistent with previous reports a significant proportion of regulated genes encoded ECM components or enzymes involved in ECM remodeling (9, 16) (Supplemental Table 1 ). One of the most strongly induced genes was NOX4 (436.6 ± 20.8 fold). Of the other known NOX and associated genes, the regulatory phox subunit p67 phox (NCF2) was also up-regulated (11.8 ± 4.7 fold). In addition, several genes encoding proteins with ROS scavenging function were significantly down-regulated, in particular Selenoprotein P plasma 1 (SEPP1, -7.2 ± 0.2 fold). These data were verified by quantitative PCR (qPCR; supplemental Figure 1 ). NOX4 and SEPP1 were 104.3 ± 8.0 and -14.2 ± 2.8 fold up-and down-regulated, respectively. The superior sensitivity of qPCR over microarray for the detection of low abundance transcripts revealed that despite their low basal expression NOX1 and NOX5 were marginally but significantly (pvalue = 0.0005) down-regulated during TGFβ1-induced transdifferentiation (-2.8 ± 0.4 and -2.9 ± 0.4 fold, respectively). NOX2 or NOX3 were not detectably expressed in PrSCs (not shown). These data suggest that TGFβ1-induced transdifferentiation of PrSCs is associated with a NOX4-driven pro-oxidant shift in redox homeostasis.
Elevated ROS production precedes fibroblast transdifferentiation
To determine the functional significance of TGFβ1-induced NOX4 expression, ROS production was measured in PrSCs. (Figure 1a ). Consistent with tetracycline-inducible NOX4 systems (25) , elevated ROS production began 
Elevated ROS during transdifferentiation are specific non-stress inducing signaling molecules
When cellular ROS scavenging activity is deficient, high ROS levels may induce non-specific damage to DNA, proteins and lipids, termed oxidative stress (19) . Oxidative stress-induced phosphorylation of p53 on Ser15 serves as an early indicator of DNA damage (28) .
Compared to positive control cells exposed to stress-inducing levels of H 2 O 2 , no detectable p53-Ser15 phosphorylation was observed in PrSCs incubated for 24-72 h with either bFGF or TGFβ1 (Figure 1c) . Moreover, total protein carbonylation, an indicator of protein oxidation, did not significantly differ between bFGF and TGFβ1 treated PrSCs (not shown). In addition, only the reduced (active) form of the redox-sensitive nuclear phosphatase PTEN, which migrates slower under non-reducing SDS-PAGE relative to the oxidized (inactive) phosphatase (29) , was present in lysates of PrSCs stimulated for 24 h with bFGF or TGFβ1
( Figure 1d ). Thus, despite sustained elevated ROS levels and reduced expression of ROS scavenging enzymes, ROS produced in response to TGFβ1 act as specific, non-stress inducing signaling molecules.
NOX4 is essential for fibroblast-to-myofibroblast transdifferentiation
To confirm that NOX4 is the ROS-producing source in response to TGFβ1, lentiviral- 
NOX4 coordinates cytokine-induced phosphorylation cascades
The intracellular response to cytokines including TGFβ1 is transduced by the concerted action of numerous kinases and phosphatases, whose activity is frequently sensitive to changes in redox homeostasis. We therefore examined the effect of NOX4 silencing on the phosphorylation status of different kinases during transdifferentiation. NOX4 KD reduced 
ERK1/2 and JNK kinases are required post-translationally for NOX4-derived ROS production
Kinase inhibitors were employed to evaluate the requirement of ERK1/2 and JNK kinases during transdifferentiation and compared to the effect of an ALK5/TGFβ receptor I (TGFβRI) inhibitor (SB413542). PKC inhibitors were also studied as PKC is implicated in regulating NOX isoforms at the transcriptional and post-translational level (32) . Whilst an inhibitor of Ca 2+ -dependent PKC isoforms (RO320432) had no significant effect on TGFβ1-induced ROS production or NOX4 expression ( Figure 3 ), a pan PKC inhibitor (RO318220) significantly reduced ROS production by 57% ± 5.9 ( Figure 3a ) and partially attenuated TGFβ1 induction of NOX4 mRNA (-3.0 fold ± 0.7; Figure 3b ). However, transdifferentiation marker mRNA and protein levels were unchanged compared to cells treated with TGFβ1 alone ( 
Negative feedback of NOX4-derived ROS via ERK1/2 phosphorylation
In Given that pharmacological inhibition of ERK1/2 (PD98059) appears to attenuate NOX4-mediated ROS production at a post-translational level ( Figure 3 ), we next investigated whether late phase ERK1/2 phosphorylation may drive NOX4-dependent ROS production.
Exposure of PrSCs to the MEK inhibitor PD98059 at a time point post TGFβ1 stimulation when late phase ERK1/2 phosphorylation has commenced (6 h) was sufficient to reduce TGFβ1-induced ROS production by 73.7% (± 5.6) and comparable to when the inhibitor was added prior to TGFβ1 stimulation (60.7% ± 2.6 at 0 h; Figure 4c ). Thus, a complex feedback loop appears to exist in which NOX4-derived ROS coordinates the absolute level ERK1/2 phosphorylation, which in turn post-translationally regulates NOX4-derived ROS production.
NOX4 coordinates the expression of dual-specificity phosphatases during transdifferentiation
The catalytic activity of JNK and ERK1/2 is regulated by numerous phosphatases, in particular the MAPK phosphatase (MKPs) subset of dual specificity phosphatases (DUSPs), which display different tissue-specific expression, subcellular localization and MAPK substrate specificity (33, 34) . Microarray data indicated that DUSP2, -6 and -10 are regulated 48 h after TGFβ1 stimulation, a finding confirmed by qPCR (24 h post TGFβ1 stimulation). These findings are consistent with decreased expression of cytoplasmic DUSP6 and increased nuclear DUSP2 during TGFβ1-induced transdifferentiation and attenuation of these changes upon NOX4 silencing (Figure 5a ). Collectively, these data indicate that transdifferentiation is associated with a NOX4-dependent restriction of pERK to the cytosol/ER.
NOX4 expression correlates with the myofibroblast phenotype in vivo
The data thus far implicate NOX4 in driving TGFβ1-mediated fibroblast-to-myofibroblast transdifferentiation. We therefore investigated whether NOX4 may play a role in the pathogenesis of BPH and PCa in which stromal remodeling and fibroblast transdifferentiation into myofibroblasts is characteristic. NOX4 expression was verified by qPCR in non-tumor containing small prostate samples derived from radical prostatectomies (n = 13, Figure 6a) and compared to the expression of epithelial-, stromal-and myofibroblast-specific markers 
Loss of SEPP1 in tumor-associated stroma of human prostate biopsies
Selenium (Se) is an essential micronutrient that is incorporated as selenocysteine (Se-Cys)
at the active site of selenoproteins, including SEPP1. Due to its high levels in plasma together with an unusually high Se-Cys content, SEPP1 is thought to predominantly function as a Se transport protein, however it may also possess intrinsic antioxidant properties (35, 36) . SEPP1 was significantly down-regulated during transdifferentiation (-14.2 ± 2.8 fold by qPCR; supplemental Figure 1 ), a finding confirmed at the protein level (Figure 6c ; -2.4 ± 0.2 fold).
To determine whether loss of SEPP1 is associated with pathogenic stromal remodeling in vivo, prostate biopsies from normal/BPH and PCa patients were stained for SEPP1 by immunohistochemistry (Figure 6d) . Specificity of the SEPP1 signal was verified by preblocking with a peptide corresponding to residues 244-258 of human SEPP1 against which the antibody was raised (Figure 6d ) (37) . In normal/BPH prostate (n = 3), strong SEPP1
cytoplasmic staining was observed in basal and luminal epithelial cells and SMCs.
Periglandular stromal cells (fibroblasts, perivascular and endothelial cells) were moderately stained ( Figure 6d ). However, in biopsies of PCa patients (Gleason 7, n = 3) SEPP1
immunoreactivity was specifically lost in the periglandular tumor-associated (reactive) stroma whereas adjacent bundles of smooth muscle and tumor cells stained positive (Figure 6d ).
Thus, consistent with the reduction of SEPP1 in transdifferentiated PrSCs (above), the remodeled prostatic stroma in PCa exhibits specific loss of stromal SEPP1.
Silencing of ROS signaling by selenium attenuates transdifferentiation
Se status regulates the expression and biosynthesis of selenoproteins (38, 39) . Thus, reduced Se transport by SEPP1 may result in cellular Se deficiency, which subsequently decreases selenoenzyme synthesis and ROS scavenging activity, thereby potentiating NOX4-derived ROS signaling. To investigate whether exogenous Se was sufficient to restore antioxidant activity and inhibit transdifferentiation, PrSCs were exposed to subcytotoxic concentrations (5 nM) of selenium as inorganic sodium selenite. Selenite significantly attenuated TGFβ1-induced ROS production and expression of transdifferentiation markers without significantly altering their basal levels (Figure 7a-d) . In addition, selenite elevated pERK1/2 and reduced pJNK/pSMAD2 levels as observed upon NOX4 KD (Figure 7d ).
TGFβ1-induced changes in DUSP expression were also attenuated by selenite (not shown).
Consistently, selenite inhibited phenotypic switching associated with TGFβ1-induced transdifferentiation (Figure 7c ). Moreover, selenite treatment 6 h after the addition of TGFβ1, when ROS production has already commenced ( Figure 1b ) was sufficient to attenuate TGFβ1-induced transdifferentiation (not shown). Thus, selenite not only exerts a protective effect before ROS levels increase, but also mediates its inhibitory effects during active ROS production and once the transdifferentiation cascade has been initiated.
Selenite strongly reduced TGFβ1-induced ROS levels (9.0 ± 3.8 fold, p-value = 0.01) without significantly attenuating TGFβ1 induction of NOX4 mRNA (-2.1 ± 0.3 fold, p-value = 0.07) or protein (Figure 7a-d) . This suggested that ROS scavenging activity was enhanced. Indeed, whilst selenite did not alter basal or TGFβ1-reduced CAT or SEPP1 mRNA levels, basal expression of SOD2, TXN and TXNRD1 was significantly induced by selenite (Figure 7e ).
Moreover, their down-regulation during TGFβ1-mediated transdifferentiation was completely reversed (Figure 7e ). Collectively, these data indicate that selenite abrogates the initiated TGFβ1-induced transdifferentiation cascade by restoring antioxidant activity of specific ROS scavenging enzymes, which depletes NOX4-derived ROS thereby attenuating ROS signaling.
Discussion
Stromal remodeling via fibroblast-to-myofibroblast transdifferentiation promotes the development of BPH and PCa. Elevated production of TGFβ1, a potent inducer of fibroblast transdifferentiation in vitro and in vivo, is considered to be the inducing stimulus (12, 13, 16, 18) . Several studies implicated NOX4 as a downstream TGFβ1 effector and mediator of transdifferentiation in mesenchymal cells of the heart and lung (23, 24, 40) . However, the mechanism by which NOX4-derived ROS drive transdifferentiation remained to be elucidated. We demonstrate that ROS signaling by NOX4 induces fibroblast-to-myofibroblast transdifferentiation in PrSCs by modulating the spatiotemporal activity of MAPKs that coordinate downstream cytoskeletal remodeling and phenotypic transdifferentiation (summarized Figure 8 ). To our knowledge this is the first report demonstrating dysregulation of redox homeostasis in stromal remodeling in BPH and PCa. Late phase ERK1/2 phosphoactivation may also serve as a counteracting survival pathway to overcome the apoptosis-inducing effects of sustained JNK activation (49) .
In contrast to many peptide growth factors that induce transient ROS production, PrSCs undergoing transdifferentiation produced sustained elevated levels of ROS. This may be attributed to several sources, including (i) TGFβ1-autoactivation, (ii) integrin-induced NOX4-derived ROS that activates ECM remodeling MMPs (iii) pERK/pJNK-mediated activation of NOX4-derived ROS production and (iv) elevated deposition of ECM proteins that themselves stimulate NOX4 expression and ROS production (supplemental Table 1 Selenite reduced TGFβ-induced ROS without reducing NOX4 mRNA levels, suggesting enhanced (selenoprotein) ROS scavenging activity. Supportively, selenite induced expression of the selenoenzymes TXN and TXNRD1. Selenite had no effect on SEPP1 mRNA levels, most likely due to upstream direct inhibition by TGFβ1/SMAD (54) . As a nonselenoprotein, selenite induction of SOD2 was surprising but consistent with in vitro and in vivo findings of others (55) (56) (57) . SOD2 induction may be required to ensure dismutation of superoxide, which combined with sufficient GPX activity to detoxify the resulting H 2 O 2 into water perhaps serves to protect the mitochondria from excessive ROS. Collectively, these data demonstrate that selenite attenuates fibroblast-to-myofibroblast transdifferentiation most likely via enhanced biosynthesis of ROS scavenging selenoenzymes, which depletes TGFβ1-induced NOX4-derived ROS levels thereby preventing dysregulated NOX4/ROS signaling.
These findings are consistent with a large body of data in experimental animals that Se deficiency or supplementation increase or reduce tumor incidence, respectively (58-60).
However, several large-scale clinical and epidemiological studies yielded conflicting results relating plasma Se levels to the risk of PCa and the protective effect of Se supplementation on PCa incidence (61) (62) (63) (64) . Clearly, further well-designed studies are required to encompass a number of factors that may have contributed to these inconsistencies e.g. the source and dose of the Se supplement employed, baseline Se levels, individual Se requirements and genetic variations within antioxidant and selenoprotein genes (65, 66) . However, the significant reduction in PCa incidence observed in the Nutritional Prevention of Cancer study suggests that Se supplementation may benefit subpopulations in whom activity of diseaserelevant selenoenzymes are suboptimal, perhaps due to environmental and/or genetic factors (64, 65) .
In summary, NOX4-derived ROS are essential TGFβ1 signaling effectors that define the spatiotemporal activity of ERK1/2 and JNK MAPKs via redox-specific regulation of DUSP phosphatase expression thereby activating downstream transcriptional cascades leading to fibroblast-to-myofibroblast transdifferentiation. ROS signaling is supported by the concomitant down-regulation of ROS scavenging (seleno)enzymes, which can be rescued by the addition of Se. These data demonstrate for the first time dysregulation of redox homeostasis in pathogenic activation of stromal fibroblasts in age-related proliferative diseases of the prostate and point to the potential clinical benefit of Se supplementation and/or local NOX4 inhibition in stromal-targeted therapy. Given that TGFβ signaling and myofibroblast activation are associated with numerous fibrotic disorders (e.g. idiopathic lung pulmonary fibrosis, nephrogenic systemic fibrosis, hypertrophic scarring, proliferative vitreoretinopathies, atherosclerotic lesions) and tumorigenesis, it will be interesting to see whether similar NOX4-dependent processes are at work.
Methods
Reagents
Reagents were from Sigma Aldrich unless otherwise specified. Human recombinant TGFβ1
was from R&D Systems, kinase inhibitors and concentrations employed were: TGFβ type 1 receptor activin receptor-like kinase ALK5 inhibitor SB431542 (1 µM, Tocris Bioscience), other kinase inhibitors were from Calbiochem: JNK (10 µM), SP600125; MEK, PD98059 (50 µM); PKC, RO320432 (Ca 2+ -dependent) and RO318220 (pan) (1 µM). Antibodies were obtained as follows: p53, phospho-JNK and α-tubulin (Santa Cruz), IGFBP3 and phospho-SMAD2/3 (R&D Systems), β-actin, NOX4 and α-SMA (Sigma), phospho-p53, -PKC, -ERK1/2
and PTEN (Cell Signaling), SEPP1 was a kind gift from Holger Steinbrenner (Düsseldorf, Germany), HRP-conjugated secondary antibodies (Promega).
Primary cell culture
Human primary prostatic fibroblasts (PrSCs) were established from prostate organoids as described previously (16) . PrSCs were maintained for routine culture in stromal cell growth medium (SCGM, Lonza) at 37°C in a humidified atmosphere of 5% CO 2 . For all experiments cells of passage 2-4 were used directly from culture (not previously frozen). For transdifferentiation, PrSCs were incubated for 12 h in RPMI 1640 (Lonza) supplemented with 1% charcoal-treated BCS (ctBCS; Hyclone) and antibiotics. Cells were subsequently stimulated with either 1 ng/ml bFGF as mock control or 1 ng/ml TGFβ1 for the indicated duration. For kinase inhibition, cells were pretreated for 1 h with the appropriate kinase inhibitor or DMSO equivalent before stimulation with bFGF or TGFβ1 as indicated. All experiments were performed at least three times with primary cells from at least three different donors.
RNA isolation, cDNA synthesis and qPCR
Prostate samples from the ventral part of the prostate were obtained after radical prostatectomy (n = 13), snap frozen and stored in liquid nitrogen before homogenization and total RNA isolation using TriZol reagent (Invitrogen). Total RNA from PrSCs was isolated using TriFast reagent (PeqLab). cDNA synthesis and qPCR were performed as described (16) . Primer sequences are given in Supplementary Table 2 . For PrSC experiments cDNA concentrations were normalized by the internal standard hydroxymethylbilane synthase (HMBS), a moderate copy number housekeeping gene not regulated under the experimental conditions employed. Relative changes in gene expression were calculated as described (67) . For prostate samples cDNA concentrations were normalized to HMBS and EEF1A1.
NOX4 expression was compared to the geometric mean expression (ct) value of epithelial markers (KLK3, KLK2, DPP4, EHF, CDH1, TMPRSS2, CORO2A and KRT5), stromal markers (SMA, IGF1, TGFB1I1, OGN, CNN1, PAGE4) or myofibroblast markers (COMP, PLN, RARRES1, COL4A1, TNC).
Microarrays
PrSCs from three independent donors incubated overnight in 1% ctBCS/RPMI were stimulated either with 1 ng/ml bFGF as mock control or with 1 ng/ml TGFβ1 for 48 h. 2 µg total RNA from each donor were pooled and hybridization to Affymetrix Human Genome U133 Plus 2.0 GeneChips® was performed at the Microarray Facility (Tübingen, Germany).
A biological replicate array was performed. Raw expression data were normalized using the GRCMA algorithm at CARMAweb (68, 69) . The complete microarray dataset is available at
ArrayExpress (E-MEXP-2167).
Lentiviral-mediated knockdown of NOX4
NOX4, scrambled and empty vector shRNA lentiviral particles were generated as described (70) . For viral transduction, PrSCs were seeded in appropriate vessels in SCGM. The following day, media was replenished supplemented with 8 µg/ml polybrene and viruscontaining supernatant at the MOI indicated. After 96 h, cells were incubated overnight in 1% ctBCS supplemented RPMI containing antibiotics before stimulation with 1 ng/ml TGFβ1 for the duration indicated. In all experiments, empty pLKO.1 vector and/or scramble shRNA vector (Addgene plasmid 1864) were used as controls.
ROS detection
ROS production was detected using a chemiluminescent protocol. Briefly, 20,000 PrSCs in triplicate in 24well plates were incubated overnight in 1% ctBCS in RPMI before stimulation as indicated. Cell monolayers were rinsed with pre-warmed Hanks' Buffered Salt Solution without Ca 2+ and Mg 2+ (HBSS, Lonza) and incubated with 4 U/ml horseradish peroxidase and 10 µg/ml luminol in HBSS. Luminescence was measured on a Chameleon luminescence counter (HVD Bioscience) at 37°C. Values were normalized against cell number using the Cell Titer Glo Luminescence assay reagent (Promega).
Western blotting and immunohistochemistry
Isolation of total cell lysates and Western blotting were performed as described (16) Pathology at the University Hospital Basel (Switzerland)) were processed for immunohistochemistry as described (71) . Where indicated SEPP1 antibody (1:500) was preblocked overnight at 4°C in 1% BSA/PBS containing 50µg/ml blocking peptide (244-258aa, Alta Bioscience, UK).
Preparation of membrane and cytosolic extracts for NOX4 detection
For NOX4 detection by Western blotting, PrSCs in 6 cm dishes were scraped into 100 µl PBS containing COMPLETE® protease inhibitor cocktail (Roche) and snap-frozen in liquid N 2 . Upon thawing, samples were vortexed, sonicated briefly and centrifuged at 13,000 rpm for 15 min at 4°C. Supernatants (cytosolic extracts) were recovered and protein content 
Statistical analysis
Numerical data are presented as mean ±SEM from at least three independent experiments using independent donors. Statistical evaluation was performed using a Student's t-test (ns, not significant; *, p < 0.05; **, p < 0.01). 
Figure 4
Co-dependency of NOX4-derived ROS production and ERK phosphorylation. 
Figure 7
Selenite inhibits TGFβ1-mediated fibroblast-to-myofibroblast transdifferentiation. PrSCs were pre-treated for 12 h with 5 nM sodium selenite or mock control before stimulation with 1 ng/ml bFGF or TGFβ1 for a further 24 h. Cells were subsequently processed for qPCR of the indicated genes (A, E), ROS determination (B), phase contrast microscopy (C) or Western blotting of total cell lysates using the antibodies indicated (D). For NOX4 detection membrane extract (ME) of cells was prepared in parallel. 
Figure 8
Signaling by NOX4-derived ROS drives TGFβ1-mediated fibroblast-tomyofibroblast transdifferentiation. Dimeric ligand binding brings homodimers of TGFβRI and TGFβRII into close proximity enabling phosphorylation of TGFβRI by the constitutively active TGFβRII. Activated heterotetrameric TGFβRs subsequently phosphorylate PKC, ERK and the C-terminal domain of SMAD2/3. Transient ERK dephosphorylation may arise via TGFβ1 induction of the immediate early gene (72) . NOX4 transcriptional induction is mediated via Ca 2+ -indepdent PKC isoforms and other unidentified factors, most likely pSMAD2/3 (24). NOX4-derived ROS promotes sustained JNK phosphorylation via downregulation of DUSP10 leading to transcriptional activation of transdifferentiation programs, e.g. SMA. pJNK positively influences ROS production by NOX4 at a post-translational level. Apoptosis induction due to sustained pJNK may be counteracted by survival pathways, including ERK, whose phospho-levels are determined by the relative activity of NOX4-dependent (inhibitory) and NOX4-independent (stimulatory) mechanisms. Late phase ERK phosphorylation is required for NOX4-derived ROS production, which in turn restricts pERK spatially to the cytoplasm via downregulation of DUSP6 and up-regulation of DUSP2. This promotes activation of cytoplasmic ERK substrates including cytoskeletal proteins (e.g. paxillin and stathmin), cytosolic kinases and transcription factors that induce myofibroblast markers e.g. IGFBP3. (encircled P, phospho-groups: broken arrows, mechanisms presumed to occur during PrSC transdifferentiation but which have been reported by others: black features, NOX4-independent mechanisms; red features, NOX4-dependent mechanisms).
